相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Formononetin represses cervical tumorigenesis by interfering with the activation of PD-L1 through MYC and STAT3 downregulation
Jing Ying Wang et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2022)
Prostate Cancer Therapy Using Docetaxel and Formononetin Combination: Hyaluronic Acid and Epidermal Growth Factor Receptor Targeted Peptide Dual Ligands Modified Binary Nanoparticles to Facilitate the in vivo Anti-Tumor Activity
Zhaoqiang Dong et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2022)
The mechanism of formononetin/calycosin compound optimizing the effects of temozolomide on C6 malignant glioma based on metabolomics and network pharmacology
Songya Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Formononetin exhibits anticancer activity in gastric carcinoma cell and regulating miR-542-5p
Wei-Song Wang et al.
KAOHSIUNG JOURNAL OF MEDICAL SCIENCES (2021)
Thymoquinone, the Most Prominent Constituent of Nigella Sativa, Attenuates Liver Damage in Streptozotocin-Induced Diabetic Rats via Regulation of Oxidative Stress, Inflammation and Cyclooxygenase-2 Protein Expression
Saleh A. Almatroodi et al.
APPLIED SCIENCES-BASEL (2021)
Formononetin relieves the facilitating effect of lncRNA AFAP1-AS1-miR-195/miR-545 axis on progression and chemo-resistance of triple-negative breast cancer
Jingjing Wu et al.
Aging-US (2021)
Potential Therapeutic Targets of Curcumin, Most Abundant Active Com-pound of Turmeric Spice: Role in the Management of Various Types of Cancer
Saleh A. Almatroodi et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2021)
Cartilage-targeting poly(ethylene glycol) (PEG)-formononetin (FMN) nanodrug for the treatment of osteoarthritis
Wei Xiong et al.
JOURNAL OF NANOBIOTECHNOLOGY (2021)
Biosynthesis of silver nanoparticles using Tamarix articulata leaf extract: an effective approach for attenuation of oxidative stress mediated diseases
Shehwaz Anwar et al.
INTERNATIONAL JOURNAL OF FOOD PROPERTIES (2021)
Formononetin, J1 and J2 have different effects on endothelial cells via EWSAT1-TRAF6 and its downstream pathway
Xin Li et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Structural Mechanisms of PTEN Regulation
Glenn R. Masson et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2020)
Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy
Asmita Pal et al.
FRONTIERS IN MICROBIOLOGY (2020)
Formononetin inhibits tumor growth by suppression of EGFR-Akt-Mcl-1 axis in non-small cell lung cancer
Xinyou Yu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Epigallocatechin-3-Gallate (EGCG), an Active Compound of Green Tea Attenuates Acute Lung Injury Regulating Macrophage Polarization and Krupple-Like-Factor 4 (KLF4) Expression
Saleh A. Almatroodi et al.
MOLECULES (2020)
Formononetin inhibits osteosarcoma cell proliferation and promotes apoptosis by regulating the miR-214-3p/phosphatase and tensin homolog pathway
Kang Li et al.
TRANSLATIONAL CANCER RESEARCH (2020)
Amla (Emblica officinalis): Role in health management via controlling various biological activities
Saleh A. Almatroodi et al.
GENE REPORTS (2020)
Formononetin Enhances the Tumoricidal Effect of Everolimus in Breast Cancer MDA-MB-468 Cells by Suppressing the mTOR Pathway
Qianmei Zhou et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2019)
In vitro and in vivo studies of antiosteosarcoma activities of formononetin
Wei Hu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Novel hybrids of podophyllotoxin and formononetin inhibit the growth, migration and invasion of lung cancer cells
Chengli Yang et al.
BIOORGANIC CHEMISTRY (2019)
Discovery and anticancer evaluation of a formononetin derivative against gastric cancer SGC7901 cells
Jian-Ning Yao et al.
INVESTIGATIONAL NEW DRUGS (2019)
Focus on Formononetin: Anticancer Potential and Molecular Targets
Samantha Kah Ling Ong et al.
CANCERS (2019)
Potential Anticancer Properties and Mechanisms of Action of Formononetin
Dongjun Jiang et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Formononetin: A Review of Its Anticancer Potentials and Mechanisms
Kai-Ching Tay et al.
FRONTIERS IN PHARMACOLOGY (2019)
Formononetin Regulates Multiple Oncogenic Signaling Cascades and Enhances Sensitivity to Bortezomib in a Multiple Myeloma Mouse Model
Chulwon Kim et al.
BIOMOLECULES (2019)
Formononetin and metformin act synergistically to inhibit growth of MCF-7 breast cancer cells in vitro
Min Xin et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Synergistic Anticancer Effects of Formononetin and Temozolomide on Glioma C6 Cells
Xiong Zhang et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2018)
Formononetin-induced oxidative stress abrogates the activation of STAT3/5 signaling axis and suppresses the tumor growth in multiple myeloma preclinical model
Chulwon Kim et al.
CANCER LETTERS (2018)
Pharmacokinetics and Bioavailability of the Isoflavones Formononetin and Ononin and Their in Vitro Absorption in Ussing Chamber and Caco-2 Cell Models
Li-Yu Luo et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2018)
The O-methylated isoflavone, formononetin, inhibits human ovarian cancer cell proliferation by sub G0/G1 cell phase arrest through PI3K/AKT and ERK1/2 inactivation
Sunwoo Park et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Development of a promising drug delivery for formononetin: Cyclodextrin-modified single-walled carbon nanotubes
Xiaohong Liu et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2018)
Formononetin, an isoflavone from Astragalus membranaceus inhibits proliferation and metastasis of ovarian cancer cells
Jing Zhang et al.
JOURNAL OF ETHNOPHARMACOLOGY (2018)
Preliminary study on conjugation of formononetin with multiwalled carbon nanotubes for inducing apoptosis via ROS production in HeLa cells
Bohong Guo et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Design and synthesis of formononetin-dithiocarbamate hybrids that inhibit growth and migration of PC-3 cells via MAPK/Wnt signaling pathways
Dong-Jun Fu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Characterization and cytotoxicity of PLGA nanoparticles loaded with formononetin cyclodextrin complex
Bohong Guo et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2017)
Recent advances of bispecific antibodies in solid tumors
Shengnan Yu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Clinical relevance and implications of HPV-induced neoplasia in different anatomical locations
Elena Sophie Prigge et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2017)
Formononetin inhibits human bladder cancer cell proliferation and invasiveness via regulation of miR-21 and PTEN
Yiying Wu et al.
FOOD & FUNCTION (2017)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015 A Systematic Analysis for the Global Burden of Disease Study
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2017)
mTORC2 promotes type I insulin-like growth factor receptor and insulin receptor activation through the tyrosine kinase activity of mTOR
Yancun Yin et al.
CELL RESEARCH (2016)
Preparation and in vivo/in vitro evaluation of formononetin phospholipid/vitamin E TPGS micelles
Xudong Cheng et al.
JOURNAL OF DRUG TARGETING (2016)
Update on Survival in Osteosarcoma
Megan E. Anderson
ORTHOPEDIC CLINICS OF NORTH AMERICA (2016)
Low concentration of formononetin stimulates the proliferation of nasopharyngeal carcinoma cell line CNE2 by upregulating bcl-2 and p-ERK1/2 expression
Yan Hong Guo et al.
PHARMACEUTICAL BIOLOGY (2016)
A 90-day subchronic toxicity study with sodium formononetin-3′-sulphonate (Sul-F) delivered to dogs via intravenous administration
Chunmei Li et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2016)
Formononetin Induces Apoptosis of Human Osteosarcoma Cell Line U2OS by Regulating the Expression of Bcl-2, Bax and MiR-375 In Vitro and In Vivo
Wei Hu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Antiproliferative effects of formononetin on human colorectal cancer via suppressing cell growth in vitro and in vivo
Jiahao Huang et al.
PROCESS BIOCHEMISTRY (2015)
Acute toxicity of sodium formononetin-3′-sulphonate (Sul-F) in Sprague-Dawley rats and Beagle dogs
Guisheng Li et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2015)
The nuclear translocation of ERK1/2 as an anticancer target
Alexander Plotnikov et al.
NATURE COMMUNICATIONS (2015)
Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models
Xiao Yu Wu et al.
ONCOTARGET (2015)
Up-regulating of RASD1 and Apoptosis of DU-145 Human Prostate Cancer Cells Induced by Formononetin in Vitro
Xiao-Jia Liu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
The MAPK Pathway Across Different Malignancies: A New Perspective
Mauricio Burotto et al.
CANCER (2014)
The Proapoptotic Effect of Formononetin in Human Osteosarcoma Cells: Involvement of Inactivation of ERK and Akt Pathways
Yun Liu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)
Formononetin Promotes Cell Cycle Arrest via Downregulation of Akt/Cyclin D1/CDK4 in Human Prostate Cancer Cells
Tianyu Li et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)
Formononetin Inhibits Migration and Invasion of MDA-MB-231 and 4T1 Breast Cancer Cells by Suppressing MMP-2 and MMP-9 Through PI3K/AKT Signaling Pathways
R. Zhou et al.
HORMONE AND METABOLIC RESEARCH (2014)
Formononetin Induces Apoptosis in PC-3 Prostate Cancer Cells Through Enhancing the Bax/Bcl-2 Ratios and Regulating the p38/Akt Pathway
Xing Zhang et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2014)
Formononetin induces the mitochondrial apoptosis pathway in prostate cancer cells via downregulation of the IGF-1/IGF-1R signaling pathway
Wen-Jun Huang et al.
PHARMACEUTICAL BIOLOGY (2014)
The ErbB/HER family of protein-tyrosine kinases and cancer
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2014)
In vitro and in vivo anti-cancer activity of formononetin on human cervical cancer cell line HeLa
Yue-mei Jin et al.
TUMOR BIOLOGY (2014)
Formononetin potentiates epirubicin-induced apoptosis via ROS production in HeLa cells in vitro
Yu-Li Lo et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2013)
Synthesis and antitumor activity of formononetin nitrogen mustard derivatives
Jie Ren et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
Biology and significance of the JAK/STAT signalling pathways
Hiu Kiu et al.
GROWTH FACTORS (2012)
Formononetin-induced Apoptosis of Human Prostate Cancer Cells Through ERK1/2 Mitogen-activated Protein Kinase Inactivation
Y. Ye et al.
HORMONE AND METABOLIC RESEARCH (2012)
Formononetin Attenuates IL-1β-Induced Apoptosis and NF-κB Activation in INS-1 Cells
Yao Wang et al.
MOLECULES (2012)
Novel anti-angiogenic effects of formononetin in human colon cancer cells and tumor xenograft
Kathy Ka-Wai Auyeung et al.
ONCOLOGY REPORTS (2012)
PAMPA permeability, plasma protein binding, blood partition, pharmacokinetics and metabolism of formononetin, a methoxylated isoflavone
Sheelendra Pratap Singh et al.
FOOD AND CHEMICAL TOXICOLOGY (2011)
Formononetin Induces Cell Cycle Arrest of Human Breast Cancer Cells via IGF1/PI3K/Akt Pathways In Vitro and In Vivo
J. Chen et al.
HORMONE AND METABOLIC RESEARCH (2011)
Aberrant promoter methylation and inactivation of PTEN gene in cervical carcinoma from Indian population
M. Moshahid Alam Rizvi et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
Matrix Metalloproteinases Contribute Distinct Roles in Neuroendocrine Prostate Carcinogenesis, Metastasis, and Angiogenesis Progression
Laurie E. Littlepage et al.
CANCER RESEARCH (2010)
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kai Kessenbrock et al.
CELL (2010)
Quantitative determination of formononetin and its metabolite in rat plasma after intravenous bolus administration by HPLC coupled with tandem mass spectrometry
Sheelendra Pratap Singh et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2010)
AKT/mTOR Pathway Activation and BCL-2 Family Proteins Modulate the Sensitivity of Human Small Cell Lung Cancer Cells to RAD001
Marin Marinov et al.
CLINICAL CANCER RESEARCH (2009)
Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members
D. L. Wheeler et al.
ONCOGENE (2008)
Inflammation and cancer: An ancient link with novel potentials
S. Perwez Hussain et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Paradoxical roles of the immune system during cancer development
KE de Visser et al.
NATURE REVIEWS CANCER (2006)
Formononetin, a phyto-oestrogen, and its metabolites up-regulate interleukin-4 production in activated T cells via increased AP-1 DNA binding activity
J Park et al.
IMMUNOLOGY (2005)
Integrin β1 signaling is necessary for transforming growth factor-β activation of p38MAPK and epithelial plasticity
NA Bhowmick et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
STAM/EAST/Hbp adapter proteins - integrators of signalling pathways
O Lohi et al.
FEBS LETTERS (2001)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
Transforming growth factor-beta 1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism
NA Bhowmick et al.
MOLECULAR BIOLOGY OF THE CELL (2001)
Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis
S Curran et al.
EUROPEAN JOURNAL OF CANCER (2000)
分享论文
